Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
176
datasets available to search
ShareScore release 0.9.0
Dataset results
176 results for “abemaciclib”
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
ClinicalTrials.gov study NCT05065411. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
ClinicalTrials.gov study NCT04750928. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
ClinicalTrials.gov study NCT04791384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
ClinicalTrials.gov study NCT06498648. IPD Sharing: YES. Countries: 1. Publications: 0.
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
ClinicalTrials.gov study NCT06169371. IPD Sharing: NO. Countries: 1. Publications: 0.
SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma
ClinicalTrials.gov study NCT04967521. IPD Sharing: NO. Countries: 1. Publications: 0.
CDK4/6 Tumor, Abemaciclib, Paclitaxel
ClinicalTrials.gov study NCT04594005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
ClinicalTrials.gov study NCT04391595. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04633239. IPD Sharing: YES. Countries: 1. Publications: 0.
A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC
ClinicalTrials.gov study NCT05766410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC
ClinicalTrials.gov study NCT04565054. IPD Sharing: NO. Countries: 3. Publications: 0.
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
ClinicalTrials.gov study NCT06413706. IPD Sharing: YES. Countries: 10. Publications: 0.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ClinicalTrials.gov study NCT06810544. IPD Sharing: NO. Countries: 1. Publications: 0.
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
ClinicalTrials.gov study NCT04158362. IPD Sharing: YES. Countries: 1. Publications: 0.
Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients
ClinicalTrials.gov study NCT02831530. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)
ClinicalTrials.gov study NCT06594679. IPD Sharing: NO. Countries: 1. Publications: 0.
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
ClinicalTrials.gov study NCT04305834. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer
ClinicalTrials.gov study NCT07292207. IPD Sharing: YES. Countries: 1. Publications: 0.
Abemaciclib in Newly Diagnosed Meningioma Patients
ClinicalTrials.gov study NCT05940493. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT03988114. IPD Sharing: YES. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.